Trade Summary

2 days ago, Norwalk Leslie V, serving as Dir at Neurocrine Biosciences Inc (NBIX), sold 3,810 shares at $155.01 per share, for a total transaction value of $590,601.00. Following this transaction, Norwalk Leslie V now holds 2,429 shares of NBIX.

This sale represents a 61.00% decrease in Norwalk Leslie V's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 12, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 14, 2026 at 4:45 PM ET, 2 days after the trade was made.

Neurocrine Biosciences Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.